Search

everythinglearnresearchcommunity

for

Search:↓

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Most low-level light therapy studies did not accurately report how light was measured, affecting treatment reliability.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Fat from the body can help improve hair growth and scars when used in skin treatments.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

The document concludes that the effectiveness of platelet rich plasma in aesthetic surgery is unclear due to inconsistent reporting and lack of objective measures in studies.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Hydrogels could lead to better treatments for wound healing without scars.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Some medications can cause acne, and stopping these drugs is the main treatment.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

PRP shows promise for hair loss treatment, with three initial monthly injections and maintenance every 3-6 months.